biotech · PTSD - Post Traumatic Stress Disorder · P1b: Advanced Solid Tumors · CMPX
Compass Therapeutics
Compass Therapeutics patent portfolio — 100 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 80 Guest Street, Suite 601, Boston, MA 02135, US
- Founded
- 2014
- Employees
- 54
- Programs
- 15
- Drugs
- 3
- Patents
- 100
Compass Therapeutics patents
100 pharmaceutical patents indexed for Compass Therapeutics. 0 expire within 24 months.
Compass Therapeutics has 100 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
Frequently asked questions
How many patents does Compass Therapeutics have?
100 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Compass Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.